Browsing Tag
Exact Sciences Corporation
4 posts
Exact Sciences stockholders approve Abbott acquisition, clearing final hurdle in $21bn cancer diagnostics deal
Exact Sciences stockholders approve Abbott’s $21 billion acquisition. Find out how the deal could reshape cancer diagnostics and investor strategy.
Abbott expands diagnostics empire with $23bn takeover of cancer-test leader Exact Sciences
Find out how Abbott’s $23B acquisition of Exact Sciences could reshape cancer diagnostics and redefine growth in oncology screening.
Guardant Health (NASDAQ: GH) surges 27% after blowout quarter: What it means for diagnostics investors
Find out how Guardant Health’s strong Q3 performance triggered a diagnostics rally — and what it means for investors in the early-detection boom.
Inocras launches MRDVision with ppm-level sensitivity, setting new standard in cancer recurrence detection
Inocras launches MRDVision with ppm-level ctDNA sensitivity, setting a new MRD testing standard—discover how it could transform cancer monitoring today.